Introduction {#s1}
============

The genome contains a complex set of instructions for the assembly and maintenance of an organism. A fundamental goal in biology is to understand the relationship between genotype and phenotype. This goal can be achieved in part by studying the genetic basis of gene expression, as many genotype-phenotype correlations are a consequence of genetically driven variation in gene expression [@pgen.1001317-Cookson1]. A number of studies have mapped individual *cis* and *trans* regulatory variants in humans, and recent work has suggested that the majority of regulators act in *trans* [@pgen.1001317-Schadt1]-[@pgen.1001317-Cheung1]; regulation of gene expression has also been widely studied in animal models [@pgen.1001317-Chesler1]-[@pgen.1001317-Petretto2]. However, the bulk of variability in gene expression remains unexplained. Heritability analyses can shed light on the genetic basis of gene expression. Several previous studies have demonstrated substantial overall heritability of gene expression in family data sets, and heritability approaches have also been broadly applied to other phenotypes [@pgen.1001317-Monks1]-[@pgen.1001317-Visscher1].

In this study, we used gene expression measurements [@pgen.1001317-Emilsson1] and genome-wide single nucleotide polymorphism (SNP) data [@pgen.1001317-Kong1] from 722 Icelanders from family cohorts to examine the heritability of gene expression in blood and adipose tissue. By studying more than one tissue type, we were able to analyze the regulation of gene expression both within and across tissues. Our goal was to answer three key questions about gene expression heritability. First, can heritability be partitioned into *cis* and *trans* components using local and genome-wide IBD between pairs of individuals? Second, to what extent are heritable components of variance shared across tissues? Third, to what extent does heritability extend to distantly related individuals inheriting IBD segments from distant ancestors?

We sought to partition the heritability of gene expression into *cis* versus *trans* components by comparing the effects of IBD at the genome-wide level (*trans*) to those of IBD at the local level (*cis*), defined as the number of chromosomes (0, 1 or 2) shared IBD at the genomic location containing the expressed gene. Our results show a substantially higher proportion of heritability due to *cis* regulation, 37% in blood and 24% in adipose tissue, than the 12% reported in a previous ancestry-based study of lymphoblastoid cell lines (LCL) in African Americans [@pgen.1001317-Price1]. One possible explanation for this discrepancy is transgenerational epigenetic inheritance, which is one of the explanations proposed to account for the "missing heritability" in genetic studies of human traits [@pgen.1001317-McCarthy1]-[@pgen.1001317-Jablonka1]. Epigenetic inheritance would regulate gene expression at the *cis* locus, and would be expected to contribute to *cis* heritability in family-based analyses but not in ancestry-based analyses, given that this mode of inheritance persists over a relatively short time scale. However, by using IBD in distantly related individuals to produce similar estimates of *cis* heritability, we were able to rule out this hypothesis. Instead, our analyses indicate that the proportion of heritability attributable to *cis* regulation is tissue-specific, and that similarities in gene expression across tissues are primarily due to heritable *cis* effects. Thus, the proportion of gene expression heritability attributable to *cis* regulation is expected to increase as a function of the number of different cell types present in the tissue being assayed, consistent with results obtained from blood, adipose tissue and LCL.

Methods {#s2}
=======

Ethics statement {#s2a}
----------------

This research was approved by the Data Protection Commission of Iceland and the National Bioethics Committee of Iceland. The appropriate informed consent was obtained for all sample donors.

Icelandic Family Blood cohort {#s2b}
-----------------------------

Relative abundances of 23,720 transcripts were obtained for blood samples from each of 1,001 individuals from the IFB cohort, as described previously [@pgen.1001317-Emilsson1] (see Web Resources). Values were adjusted for sex and age. We removed 4,985 transcripts that either had \>5% missing data, did not map to an autosomal chromosome, or mapped to more than one genomic location. We removed 16 individuals with \>5% missing data and 269 individuals for which long-range phased SNP data were not available. This left 18,735 transcripts and 716 individuals. Most of out analyses focused on 2,233 related pairs (individuals from the same family pedigree with genome-wide IBD \>0.05) spanning a subset of 687 individuals.

Icelandic Family Adipose cohort {#s2c}
-------------------------------

Relative abundances of 23,720 transcripts were obtained for adipose tissue samples from each of 673 individuals from the IFA cohort, as described previously [@pgen.1001317-Emilsson1] (see Web Resources). Values were adjusted for sex, age and body mass index (BMI), restricting to 638 individuals with BMI data. We removed 4,621 transcripts that either had \>5% missing data, did not map to an autosomal chromosome, or mapped to more than one genomic location. We removed 2 individuals with \>5% missing data and 67 individuals for which long-range phased SNP data were not available. This left 19,099 transcripts and 569 individuals. Most of our analyses focused on 1,700 related pairs (individuals from the same family pedigree with genome-wide IBD \>0.05) spanning a subset of 531 individuals.

Local IBD estimates {#s2d}
-------------------

Individuals were genotyped using the Illumina 300K chip. Owing to the sensitive nature of genotype data, access to these data can only be granted at the headquarters of deCODE Genetics in Iceland. Given long-range phased Illumina 300K data [@pgen.1001317-Kong1] for a pair of individuals, we partitioned the genome into 2cM blocks and for each block performed 2×2 = 4 comparisons between haplotypes from the two individuals. We declared two haplotypes to be IBD if they matched at \>95% of alleles in the block, non-IBD if they matched at \<85% of alleles, and unknown-IBD otherwise. We excluded SNPs with missing data in one or both individuals, so that lack of a match implies a mismatch, and set IBD status to unknown for pairs of haplotypes with \>5% of SNPs excluded. We defined local IBD as the total number of comparisons producing a match. We verified that this approach infers 0∶1∶2 copies IBD between parent-child pairs with probabilities 0.2%∶99.3%∶0.4% and 0∶1∶2: copies IBD between sibling pairs with probabilities 24.9%∶50.1%∶24.9%, excluding from this computation the 7% of pairs and blocks for which inferred IBD was unknown. These numbers are a function of the thresholds we used to define IBD and non-IBD; the thresholds were largely chosen for specificity rather than sensitivity since for our application it does not matter that inferred IBD is sometimes unknown. The numbers are very close to the expected theoretical probabilities (for parent-child pairs, 2 copies IBD is expected to occasionally occur due to IBD in "unrelated" parents). This validates our use of long-range phased SNP genotypes to compute local IBD estimates. We computed genome-wide IBD estimates as the average of local IBD estimates across all 2cM blocks.

Heritability estimates using genome-wide IBD only {#s2e}
-------------------------------------------------

We applied variance-components methods to estimate narrow-sense heritability [@pgen.1001317-Visscher1], [@pgen.1001317-Amos1]. The source code used in our heritability analyses is available for download (see Web Resources). Let *e~gs~* denote the gene expression for gene *g* and individual *s*, normalized to have mean 0 and variance 1 across individuals. Let *θ~st~* denote the genome-wide IBD between individuals *s* and *t* (0≤*θ~st~*≤1) and be the *N*×*N* matrix of genome-wide IBD, where *N* is the number of individuals. Let *V~g~* denote the covariance matrix of normalized gene expression for gene *g*. We consider the model and fit *h~g~*^2^, the heritability of gene *g*, to the observed normalized gene expression values *e~gs~* by maximizing the likelihood , where . Values of *e~gs~*, *h~g~* and *V~g~* vary with tissue type, but we view tissue type as an implicit index rather than an explicit index for simplicity of notation. For both blood and adipose tissue, the estimated values of *h~g~*^2^ were ∼80% correlated to values that were computed previously using similar methods [@pgen.1001317-Emilsson1], despite the fact that the current analysis was restricted to a subset of individuals for which long-range phased SNP data was available for local IBD inference. We declare *h~g~*^2^\>0 to be nominally significant (P\<0.05) if *h~g~*^2^ is larger than each value analogously estimated from 19 data sets with sample labels randomly permuted (thus, 5% of genes will be nominally significant even in the absence of a true effect). We estimated average *h*^2^ as the average of *h~g~*^2^ across genes *g*. We computed standard errors on *h*^2^ by performing independent runs with sample labels randomly permuted; we obtained identical standard errors using either five permutations or 20 permutations. Similar procedures were used in the *cis* vs. *trans* and cross-tissue analyses described below.

Heritability estimates using both *cis* and *trans* IBD {#s2f}
-------------------------------------------------------

We extended the variance-components approach to *cis* and *trans* heritability via the model , where is the *N*×*N* matrix of local (*cis*) IBD between individuals *s* and *t* at the genomic location proximal to gene *g*. We used the midpoint of the gene expression probe to define genomic location, but the value of *γ~gst~* is not sensitive to this choice as local IBD segments between related individuals span many megabases. We scale *γ~gst~* to have value 0.0, 0.5, or 1.0 (for 0, 1, or 2 copies shared). We fit the *cis* heritability *h~g,cis~*^2^ and *trans* heritability *h~g,trans~*^2^ by maximizing the usual likelihood, fitting *h~g~*^2^ = *h~g,cis~*^2^+*h~g,trans~*^2^ and *h~g,cis~*^2^ in turn. We average across genes *g* to estimate *h~cis~*^2^ and *h~trans~*^2^. We define the proportion of heritable gene expression variation that is due to *cis* regulation as *π~cis~*  =  *h~cis~*^2^*/*(*h~cis~*^2^+*h~trans~*^2^). As above, all values vary with tissue type, which we view as an implicit index.

Cross-tissue analysis {#s2g}
---------------------

The cross-tissue correlation *ρ* was computed as the correlation between normalized expression levels in blood and adipose tissue across genes and individuals. Due to the normalization, this is equal to the average of gene-specific correlations *ρ~g~*. We computed standard errors of both gene-specific and average cross-tissue correlations via jackknife, repeating the computation with each individual removed in turn and estimating the standard error as times the standard deviation of the *N* estimates. We now describe our estimation of cross-tissue heritability. Let and denote normalized expression levels for gene *g* and individual *s* in blood and adipose tissue, respectively. Let *W~g~* denote the covariance matrix of the vector (*e~bg~*,*e~ag~*) of length 2*N*. Here the relevant equations are where *ξ*^2^ denotes cross-tissue heritability, *ρ* denotes cross-tissue correlation, and denotes the tensor product of a 2×2 matrix with an *N*×*N* matrix to form a 2*N*×2*N* matrix. For example, the first term of *W~g~* has entries *h~bg~*~,*cis*~^2^*γ~gst~* in the upper left *N*×*N* block, *ξ~g~*~,*cis*~^2^*γ~gst~* in the upper right *N*×*N* block, and so on. This generalization of the variance-components approach to cross-phenotype analyses has been previously described (for the case of genome-wide IBD) in an analysis of two height phenotypes, self-reported height and clinically measured height [@pgen.1001317-Macgregor1]. The likelihood is defined in the usual way, replacing *V~g~* with *W~g~* and *e~g~* with (*e~bg~*,*e~ag~*). We fit *h~bg~*^2^ = *h~bg,cis~*^2^+*h~bg,trans~*^2^, *h~bg,cis~*^2^, *h~ag~*^2^ = *h~ag,cis~*^2^+*h~ag,trans~*^2^, *h~ag,cis~*^2^, *ρ~g~*, *ξ~g~*^2^ = *ξ~g,cis~*^2^+*ξ~g,trans~*^2^ and *ξ~g,cis~*^2^ in turn. For each of the parameters estimated, we compute average values by averaging across genes *g*.

Web Resources {#s2h}
-------------

-   <http://www.ncbi.nlm.nih.gov/geo/> (Gene Expression Omnibus). Gene expression data sets have been deposited into the GEO database under accession numbers GSE7965 and GPL3991, as described previously [@pgen.1001317-Emilsson1].

-   <http://www.hsph.harvard.edu/faculty/alkes-price/software/>. The source code used in our heritability analyses is available for download, along with the results presented in [Table S1](#pgen.1001317.s005){ref-type="supplementary-material"}.

Results {#s3}
=======

Overall heritability of gene expression {#s3a}
---------------------------------------

For the analysis of gene expression in blood, we analyzed normalized intensity values for 18,735 mRNA transcripts. Analysis was restricted to 687 individuals from the IFB cohort for whom long-range phased SNP data were available (see [Methods](#s2){ref-type="sec"}). For each pair of individuals, we used the long-range phased SNP data to compute the number of chromosomes shared IBD at each location in the genome, and computed the genome-wide IBD as an average of these values ([Figure 1](#pgen-1001317-g001){ref-type="fig"}; see [Methods](#s2){ref-type="sec"}). Our initial analyses focused on 2,233 related pairs with genome-wide IBD \>0.05. For the analysis of gene expression in adipose tissue, we similarly analyzed 19,099 mRNA transcripts of 531 individuals from the IFA cohort, focusing on 1,700 related pairs with genome-wide IBD \>0.05 (see [Methods](#s2){ref-type="sec"}). The IFA cohort largely overlaps the IFB cohort, with 496 of the 722 individuals analyzed appearing in both cohorts.

![Local and genome-wide IBD.\
We plot the local relatedness (0, 1 or 2 copies IBD) between two siblings from the IFB cohort at each 2cM block on chromosome 1. The dotted line represents their genome-wide relatedness of 0.568, which is within the expected range for siblings [@pgen.1001317-Visscher2].](pgen.1001317.g001){#pgen-1001317-g001}

We estimated the overall heritability *h~g~*^2^ for each gene *g* using variance-component methods [@pgen.1001317-Visscher1] (see [Methods](#s2){ref-type="sec"}). Although estimates for each gene *g* are statistically noisy at these sample sizes, histograms show a clear positive bias for both IFB and IFA cohorts ([Figure S1](#pgen.1001317.s001){ref-type="supplementary-material"} and [Table S1](#pgen.1001317.s005){ref-type="supplementary-material"}), and *h~g~*^2^\>0 was nominally significant (P = 0.05; see [Methods](#s2){ref-type="sec"}) for an excess of genes: 42% for IFB and 63% for IFA. We computed the average *h*^2^ as the average of *h~g~*^2^ across genes *g*. A relevant question is whether or not to allow negative values of *h~g~*^2^ when computing this average [@pgen.1001317-McRae1]. Such values have no biological interpretation (except in the case of negative correlation among siblings in traits that depend on birth order). However, because values close to zero may be either increased or decreased by statistical noise---leading to negative estimates of *h~g~*^2^ for 3,031 of 18,735 genes for IFB and 1,038 of 19,099 genes for IFA---we elected to allow negative values in our main computations so as to produce an unbiased estimate of average *h*^2^. We obtained estimates of *h*^2^ = 0.150 for blood and *h*^2^ = 0.234 for adipose tissue. We obtained similar results when using a regression-based approach to estimate average *h*^2^ ([Text S1](#pgen.1001317.s008){ref-type="supplementary-material"}), which more readily lends itself to visualization ([Figure 2A and 2B](#pgen-1001317-g002){ref-type="fig"}). (When clipping negative *h~g~*^2^ values to zero, we obtained *h*^2^ = 0.159 for blood and *h*^2^ = 0.237 for adipose tissue.) Our results are consistent with previous analyses reporting that expression levels of a substantial fraction of genes are significantly heritable at the level of *h*^2^ = 0.3 or higher [@pgen.1001317-Monks1]-[@pgen.1001317-Dixon1], [@pgen.1001317-McRae1].

![Family heritability in the IFB and IFA cohorts.\
(A) Gene expression covariance (average value of product of normalized gene expression measurements) between related individuals in the IFB cohort varies with genome-wide IBD. Each point represents one pair of related individuals. The slope of this plot corresponds to the regression-based estimate of *h*^2^. (B) Same as (A), for IFA cohort. (C) Gene expression covariance between siblings for genes with 0, 1 or 2 copies IBD at the *cis* locus, minus total covariance as displayed above. The slope of this plot corresponds to the regression-based estimate of *h~cis~*^2^. The signal to noise ratio is higher in this plot due to reduced effects of systematic noise covariance. (D) Same as (C), for IFA cohort.](pgen.1001317.g002){#pgen-1001317-g002}

*Cis* versus *trans* heritability of gene expression {#s3b}
----------------------------------------------------

While estimates of overall heritability are based on genome-wide IBD, it is possible to estimate *cis* versus *trans* heritability by extending variance components to consider both local (*cis*) IBD at the genomic location close to the expressed gene, and genome-wide (*trans*) IBD (see [Methods](#s2){ref-type="sec"}). As before, analyses were restricted to 2,233 and 1,700 related pairs from the IFB and IFA cohorts, respectively. Histograms of *h~g,cis~*^2^ and *h~g,trans~*^2^ estimates for each gene *g* show a clear positive bias for both IFB and IFA cohorts ([Figure S2](#pgen.1001317.s002){ref-type="supplementary-material"} and [Table S1](#pgen.1001317.s005){ref-type="supplementary-material"}), with an excess of nominally significant (P\<0.05) genes for IFB (*h~g,cis~*^2^\>0: 16%; *h~g,trans~*^2^\>0: 19%) and IFA (*h~g,cis~*^2^\>0: 16%; *h~g,trans~*^2^\>0: 30%). For IFB, we obtained average *cis* and *trans* heritability estimates of *h~cis~*^2^ = 0.055 and *h~trans~*^2^ = 0.095, respectively, which sum to *h*^2^ = 0.150. This leads to the conclusion that the proportion of heritability of expression due to *cis* variants in blood is *π~cis~* = 37%. For IFA, we obtained estimates of *h~cis~*^2^ = 0.057 and *h~trans~*^2^ = 0.177, which sum to *h*^2^ = 0.234. This yields an estimate of *π~cis~* = 24% in adipose tissue. The values of *h*^2^ and *h~trans~*^2^ in adipose tissue are significantly higher than for blood, but *h~cis~*^2^ is similar, leading to a lower value of *π~cis~*. We obtained similar results when using a regression-based approach to estimate average *h~cis~*^2^ and *h~trans~*^2^ ([Text S1](#pgen.1001317.s008){ref-type="supplementary-material"}; [Figure 2C and 2D](#pgen-1001317-g002){ref-type="fig"}). We note that there is considerably less statistical uncertainty in estimates of *h~cis~*^2^ ([Figure 2C and 2D](#pgen-1001317-g002){ref-type="fig"}) than in estimates of *h*^2^ ([Figure 2A and 2B](#pgen-1001317-g002){ref-type="fig"}). Indeed, we obtained standard errors of *h*^2^ = 0.150±0.011, *h~cis~*^2^ = 0.055±0.001 and *h~trans~*^2^ = 0.095±0.010 for blood and *h*^2^ = 0.234±0.011, *h~cis~*^2^ = 0.057±0.002 and *h~trans~*^2^ = 0.177±0.010 for adipose tissue (see [Methods](#s2){ref-type="sec"}). These standard errors are 7-100 times lower than standard errors for single-gene heritability estimates, which are inadequate for estimating *π~cis~* (see [Text S1](#pgen.1001317.s008){ref-type="supplementary-material"}). The much lower standard errors for *h~cis~*^2^ are a consequence of variation in *cis* IBD across the genome that decouples the estimation of this parameter from the systematic noise covariance structure across all pairs of individuals (see [Text S1](#pgen.1001317.s008){ref-type="supplementary-material"}). Based on these standard errors for *h~cis~*^2^ and *h~trans~*^2^, *π~cis~* has little statistical uncertainty, although results may be affected by modeling uncertainty.

Our heritability model does not account for the possibility of phenotypic similarity in related individuals due to shared environment, which can confound estimates of heritability [@pgen.1001317-Visscher1]. We note that such effects would inflate estimates of *h*^2^ and *h~trans~*^2^, but have a negligible impact on *h~cis~*^2^, since the extent of shared environment would be related to genome-wide (*trans*) rather than local (*cis*) IBD. To investigate the possibility of confounding due to shared environment, we computed the average correlation in gene expression between spouses, who are genetically unrelated but have a shared environment. We observed average correlations of 0.074±0.042 in 33 IFB spouse pairs and 0.076±0.035 in 28 IFA spouse pairs, which are similar in magnitude to correlations between sib-sib or parent-child pairs that correspond to the average heritabilities reported above (see [Text S1](#pgen.1001317.s008){ref-type="supplementary-material"} and [Table S2](#pgen.1001317.s006){ref-type="supplementary-material"}). Thus, there is strong evidence that shared environment can lead to similarity in gene expression phenotypes. We further investigated whether the gene by gene signature of correlations in spouse pairs matches the signature of correlations in sib-sib or parent-child pairs or estimates of *h~g~*^2^, but found that it does not (see [Text S1](#pgen.1001317.s008){ref-type="supplementary-material"} and [Table S3](#pgen.1001317.s007){ref-type="supplementary-material"}). Thus, we hypothesize that the correlations in spouse pairs are due to very recent shared environment (e.g. diet) arising from sharing the same household, whereas the correlations in sib-sib and parent-child pairs in this study (who are unlikely to share the same household, since only adult individuals were sampled) are due to genetic heritability. However, we cannot rule out a small amount of inflation in *h*^2^ and *h~trans~*^2^ estimates due to shared environment in related individuals.

Assessing the impact of epigenetic inheritance on *cis* heritability {#s3c}
--------------------------------------------------------------------

Our family-based estimates of *π~cis~* in blood and adipose tissue are considerably greater than a previous estimate of 12±3% obtained using lymphoblastoid cell lines (LCL) from African-Americans, in which local versus genome-wide European ancestry was used to infer the relative contribution of *cis* versus *trans* heritability [@pgen.1001317-Price1]. An analogous ancestry-based analysis of LCL gene expression data [@pgen.1001317-Stranger2] from admixed HapMap 3 Mexican-Americans [@pgen.1001317-The1] has produced a similarly low value of *π~cis~* = 13±9%. One possible explanation for the lower values as compared to family-based estimates could be the epigenetic inheritance of *cis*-acting factors other than DNA sequence that are transmitted from parent to offspring. Given the relatively short time scale of epigenetic inheritance, this would be expected to have a much greater impact on family-based estimates of *π~cis~* than those based on ancestry [@pgen.1001317-Youngson1]-[@pgen.1001317-Jablonka1].

To further explore the epigenetic hypothesis, we repeated the *cis* versus *trans* analysis using subsets of unrelated or distantly related individuals (genome-wide IBD \<0.01) from the IFB and IFA cohorts. The mean genome-wide IBD for all such pairs of individuals was 0.0044, with a standard deviation of 0.0018, consistent with the known properties of distant relatedness between "unrelated" individuals from Iceland as well as other world populations [@pgen.1001317-Helgason1]-[@pgen.1001317-Gusev1]. We independently generated five random subsets of IFB individuals (85, 87, 92, 93, 91 individuals) and five random subsets of IFA individuals (127, 85, 92, 95, 89 individuals) with genome-wide IBD \<0.01 between each pair of individuals in each subset, such that each subset was maximal subject to this constraint. The resulting estimates of *h~cis~*^2^ were 0.057±0.008 for blood and 0.067±0.005 for adipose tissue (mean ± standard deviation across five subsets). These estimates of *h~cis~*^2^ were close to our previous estimates based on closely related pairs, thereby ruling out a substantial contribution of epigenetic inheritance to *cis* heritability (see [Discussion](#s4){ref-type="sec"}). However, we did not obtain meaningful estimates of *h~trans~*^2^ using distantly related individuals, due to the systematic noise covariance structure (see [Text S1](#pgen.1001317.s008){ref-type="supplementary-material"}), and therefore *π~cis~* could not be estimated. We note that similar results for distantly related pairs were obtained using different IBD estimation algorithms (see [Text S1](#pgen.1001317.s008){ref-type="supplementary-material"}).

Cross-tissue analysis {#s3d}
---------------------

We conducted a cross-tissue analysis of expression heritability in blood and adipose tissue in 496 individuals who overlapped between the IFB and IFA cohorts. We determined that an individual's blood expression for a particular gene is slightly but significantly correlated to the same individual's adipose expression for the same gene, with an average correlation of *ρ* = 0.041±0.005 (mean ± standard error) (see [Methods](#s2){ref-type="sec"}). Although estimates for each gene *g* are statistically noisy at these sample sizes, histograms show a clear positive bias in *ρ~g~* ([Figure S3](#pgen.1001317.s003){ref-type="supplementary-material"}), and *ρ~g~*\>0 was nominally significant (P = 0.05) for 20% of genes, a significant excess.

We next investigated the relationship between an individual's blood expression and a related individual's adipose expression, using variance-components methods (see [Methods](#s2){ref-type="sec"}). This revealed that cross-tissue similarity varies with the level of family relatedness, with an average cross-tissue heritability estimate of *ξ*^2^ = 0.030±0.006. Analogous to the analyses for single tissues, we partitioned the cross-tissue heritability into *cis* and *trans* components, yielding values of *ξ~cis~*^2^ = 0.031±0.001 and *ξ~trans~*^2^ = -0.001±0.006. We obtained similar results using regression-based approaches ([Text S1](#pgen.1001317.s008){ref-type="supplementary-material"}; [Figure 3A and 3B](#pgen-1001317-g003){ref-type="fig"}). Histograms of cross-heritability estimates for each gene *g* show a positive bias for *ξ~g~*^2^ and *ξ~g,cis~*^2^, but not *ξ~g,trans~*^2^, for which the histogram is symmetric about zero ([Figure S4](#pgen.1001317.s004){ref-type="supplementary-material"}). While our estimate of *ξ~trans~*^2^ is not significantly different from zero, *ξ~cis~*^2^ is highly significant and explains the bulk of our estimate of *ρ*. This implies that the extent to which gene expression in blood and adipose tissue is similar across genes and individuals is dominated by heritable effects at the *cis* locus.

![Cross-tissue heritability in the IFB and IFA cohorts.\
Plots are analogous to those in [Figure 2](#pgen-1001317-g002){ref-type="fig"}, except that we analyze the covariance between related individuals in *different* tissues, instead of between related individuals in the same tissue. (A) Cross-tissue covariance between related individuals in the intersection of IFB and IFA varies with genome-wide IBD. The slope of this plot corresponds to the regression-based estimate of *ξ*^2^. (B) Cross-tissue covariance between siblings in the intersection of IFB and IFA with 0, 1 or 2 copies IBD at the *cis* locus, minus total covariance as displayed in (A). The slope of this plot corresponds to *ξ~cis~*^2^.](pgen.1001317.g003){#pgen-1001317-g003}

Averaging across cell types with shared *cis* effects increases the value of *π~cis~* {#s3e}
-------------------------------------------------------------------------------------

Our finding that cross-tissue similarities are dominated by heritable *cis* effects leads to the mathematical result that *π~cis~* is expected to increase with tissue heterogeneity: as the number of cell types represented in a tissue increases, the strongly correlated *cis* effects will add linearly but the uncorrelated *trans* effects will be diluted. In detail, let *x* and *y* denote cells types and suppose that Cov(*e~xgs~*,*e~xgt~*)  =  Cov(*e~ygs~*,*e~ygt~*)  =  *h~cis~*^2^*γ~gst~*+*h~trans~*^2^*θ~st~* for all genes *g* and individuals *s*≠*t*, and that all *cis* effects (but no *trans* or non-genetic effects) are shared across cell types. Thus, Cov(*e~xgs~*,*e~ygt~*)  =  *h~cis~*^2^*γ~gst~*. Now consider a tissue *z* containing cell types *x* and *y*. Up to a normalization constant, Cov(*e~zgs~*,*e~zgt~*)  =  Cov(0.5(*e~xgs~*+*e~ygs~*),0.5(*e~xgt~*+*e~ygt~*))  =  *h~cis~*^2^*γ~gst~*+0.5*h~trans~*^2^*θ~st~*, so that *π~cis,z~*  =  *h~cis~*^2^*/*(*h~cis~*^2^+0.5*h~trans~*^2^) is larger than *π~cis,x~*  =  *π~cis,y~*  =  *h~cis~*^2^*/*(*h~cis~*^2^+*h~trans~*^2^).

We verified this theoretical result empirically by defining *e~zgs~*  =  *e~bgs~* + *e~ags~* as the average of normalized gene expression in blood and adipose tissue, normalized to mean 0 and variance 1. For synthetic tissue *z*, we obtained the value *π~cis~*  = 0.41, which is larger than the value of *π~cis~* for either blood or adipose tissue, and similar to the predicted value of 0.055/(0.055+0.25(0.095+0.177))  = 0.45 based on *h~cis~*^2^ and *h~trans~*^2^ (*π~cis~* \< 0.45 is actually expected since not *all cis* effects are shared). Thus, the variability in *π~cis~* across tissue types (0.12 for LCL, 0.24 for adipose, 0.37 for blood) is consistent with the fact that LCL represent a single cell type, whereas adipose tissue and blood contain many cell types: adipose tissue contains smooth muscle cells, fibroblasts, adipocytes, mast-cells and endothelial cells, while blood contains erythrocytes, thrombocytes, neutrophils, lymphocytes, monocytes, eosinophils and basophils in proportions that vary across individuals [@pgen.1001317-Astori1]-[@pgen.1001317-Cheung2]. This also explains why studies of individual cell types have been more successful in identifying *trans* eQTLs than studies of whole tissues, and why most replications across tissue types occur at *cis* eQTLs [@pgen.1001317-Emilsson1], [@pgen.1001317-Cheung2]-[@pgen.1001317-Idaghdour1].

Discussion {#s4}
==========

In this study, we observed a greater contribution of *cis* regulation in blood and adipose tissue than in a previous ancestry-based analysis of LCL in African-Americans [@pgen.1001317-Price1]. This result is not sensitive to sample size, because although estimates for individual genes are statistically noisy, we considered averages across genes. We also observed that cross-tissue similarity between blood and adipose expression is genetically heritable and dominated by *cis* effects. These two results are highly concordant. Due to the dilution of *trans* effects that are not shared across cell types, *cis* regulation is expected to explain a greater proportion of heritability in tissue types that are heterogeneous in their cell composition, such as blood and adipose tissue---particularly blood, in which cell type proportions may vary among individuals. This highlights the importance of considering different tissue types [@pgen.1001317-Price1]. However, other explanations for the higher contribution of *cis* regulation in this study than in the ancestry-based analysis are also possible. For example, epistasis between two neighboring *cis* variants would be included in *cis* heritabilities estimated via IBD, but not in the ancestry-based analysis in which ancestry is a partial proxy for SNP genotype but a very poor proxy for both genotypes of two interacting SNPs. In addition, epistatic interactions involving multiple loci may potentially be important, and may confound estimates of narrow-sense heritability, but are outside the scope of this study. A further possibility is that *trans* effects in LCL could be overstated due to genetically heritable variation of *in vitro* factors such as the response to EBV virus, which would mimic *trans* regulation in heritability analyses but does not reflect true biological *trans* regulation [@pgen.1001317-Choy1]. Distinguishing between these possibilities is an important direction of future work.

Efforts to understand *cis* regulation are likely to benefit from combining information from many cell or tissue types, since underlying mechanisms can be either shared or cell-type specific. Indeed, our finding that on average roughly half single-tissue *cis* heritability (*h~cis~*^2^) is shared across tissues (*ξ~cis~*^2^) is consistent with a recent study focusing on *cis* eQTLs, which reported that 54%, 50% and 54% of *cis* eQTLs in fibroblasts, LCLs and T cells, respectively, are cell-type specific [@pgen.1001317-Dimas1]. Those percentages would be expected to be higher when considering only two cell types, but lower at larger sample sizes. On the other hand, studies of *trans* regulation should focus on a single cell type to avoid diluting *trans* effects that are not shared across cell types. New technologies to assay cell type-specific gene expression in complex tissues may also prove valuable [@pgen.1001317-ShenOrr1]. Future experiments will shed light on whether similarity between tissues other than blood and adipose is also predominantly explained by heritable *cis* effects. Results may vary by organism as well as tissue type. Recent studies of fat, kidney, adrenal and heart tissues in rat recombinant inbred strains also observed reduced *trans* effects in more heterogeneous tissues, but reported some evidence of cross-tissue regulation in *trans* as well as in *cis* [@pgen.1001317-Petretto1]-[@pgen.1001317-Petretto2].

The similarity of *cis* heritability results using IBD in closely related versus distantly related individuals has significant implications. It has been suggested that epigenetic inheritance, defined as the transmission across generations of epigenetic changes not due to variation in DNA sequence, is a potential source of the "missing heritability" in genetic association studies [@pgen.1001317-McCarthy1]-[@pgen.1001317-Kaminsky1]. Epigenetic inheritance would be expected to influence expression at the *cis* locus, and would be expected to contribute to *cis* heritability between closely related individuals but not between distantly related individuals, given that this mode of inheritance persists over a relatively short time scale [@pgen.1001317-Youngson1]-[@pgen.1001317-Jablonka1]. Our failure to observe any such discordance suggests that transgenerational epigenetic inheritance is unlikely to play a major role in the missing heritability of gene expression and other traits, although it does not rule out a very small aggregate effect across all genes or large effects at certain metastable epialleles [@pgen.1001317-Morgan1]-[@pgen.1001317-Rakyan1], nor does it shed light on the importance of mitotically conserved epigenetic effects that are not transmitted from parent to offspring.

Our results highlight the utility of using IBD in distantly related individuals to make inferences about heritability. This approach will be particularly valuable as sample sizes increase, since the number of pairs of individuals increases quadratically with sample size. Indeed, IBD in distantly related individuals has already proven useful for mapping specific loci [@pgen.1001317-Kenny1], and heritability-related analyses using identity-by-state (IBS) instead of IBD have also yielded important insights [@pgen.1001317-Kang1]-[@pgen.1001317-Powell1]. By using IBD segments shorter than those analyzed here to consider IBD sharing at different distances from genes, it may even be possible draw conclusions about the distribution of genomic distances at which *cis* regulation contributes to heritability.
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Histograms of heritability estimates for each gene. We plot histograms of (a) *h~g~*^2^ estimates for IFB and (b) *h~g~*^2^ estimates for IFA, across genes *g*.
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Histograms of *cis* and *trans* heritability estimates for each gene. We plot histograms of (a) *h~g,cis~*^2^ estimates for IFB, (b) *h~g,trans~*^2^ estimates for IFB, (c) *h~g,cis~*^2^ estimates for IFA and (d) *h~g,trans~*^2^ estimates for IFA, across genes *g*.
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Histograms of cross-tissue correlations for each gene. We plot a histogram of observed gene-specific cross-tissue correlations *ρ~g~*.
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Histograms of cross-tissue heritability estimates for each gene. We plot histograms of (a) *ξ~g~*^2^ estimates, (b) *ξ~g,cis~*^2^ estimates and (c) *ξ~g,trans~*^2^ estimates, across genes.
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Average correlations between spouse-spouse, sib-sib, and parent-child pairs. We list the average correlation for each pair type and cohort, averaging across correlations for each gene *g*. We also list standard errors, computed via jackknife.
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Concordance of gene-by-gene signatures of correlations in each pair type. We list values of *R~sib-sib,parent-child~*, *R~spouse,sib-sib~* and *R~spouse,parent-child~* for each cohort (see text), along with the number of pairs of each type used to compute those values. For comparison purposes, we also list (in italics) values of *R~sib-sib,parent-child~* computed using smaller subsets of pairs to match the number of pairs used to compute *R~spouse,sib-sib~* or *R~spouse,parent-child~*, as a smaller number of pairs leads to lower values of *R*.
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